Webinar Date & Time
21 January 2026 from 04:00 PM to 05:30 PM (CET)
Webinar Overview
As the regulatory landscape for clinical trials continues to evolve, sponsors must adapt to the complex requirements introduced by the In Vitro Diagnostic Regulation (IVDR 2017/746) and the Clinical Trials Regulation (CTR 536/2014). This presentation provides a practical overview of the key compliance obligations under both frameworks, with a focus on IVDR compliant clinical trials. We will explore the implications for compliance, and regulatory submissions, highlighting common challenges and operational impacts. Attendees will gain actionable insights to support efficient trial planning and ensure alignment with current EU regulatory expectations.
Presenter
Amber McNair
Associate Director, Clinical Trials Regulatory
IQVIA
Amber McNair is an Associate Director of Clinical Trials Regulatory Affairs at IQVIA, a leading global contract research organization (CRO). She brings nearly six years of specialized experience in clinical trial regulation, with a strong focus on biomarker-driven drug development and companion diagnostics.
Amber’s scientific foundation stems from her work managing global central laboratory operations, where she managed the development and implementation of companion diagnostic strategies across complex, multi-country clinical trials. Her expertise in in vitro diagnostic (IVD) compliance, particularly within the evolving EU regulatory landscape, gives her a distinctive perspective on the integration of diagnostics into clinical trial design and execution.
She is a board-certified Medical Affairs Advisor and a Registered Scientist with the UK Science Council, underscoring her commitment to professional excellence, scientific integrity, and regulatory reliability. Amber is a passionate advocate for precision medicine and plays a key role in aligning regulatory strategy with scientific innovation to support global trial delivery.
Her work continues to drive forward the regulatory frameworks that enable biomarker-led clinical research, ensuring that diagnostic and therapeutic development remain closely aligned in pursuit of improved patient outcomes.
Attendance Fee
€ 90,- for non-EUCROF members
€ 60,- for EUCROF members
Deadline for registration
20 January 2026 at 6 p.m.
How to register?
1) Go on the REGISTRATION PAGE and click on the orange button “GET TICKETS”
2) Check your order and click on the green “CHECKOUT” button
3) Fill in all the necessary information and validate your order
Confirmation
You will receive 2 confirmation emails:
A) One from Eventbrite with your invoice
B) One from “Eucrof” with all the necessary information to connect the D-Day!
Questions?
Should you have any questions about registration, invoices or connection, do not hesitate and contact us by email at webinar@eucrof.eu
By registering to the webinar, you give your authorisation to the webinar organizers to use your email address and personal information to communicate with you about this event and future initiatives. To stop receiving their communications, please contact the organizers directly at info@eucrof.eu.
